Personal Care Products Safety Act

Summary

Personal Care Products Safety Act This bill amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. Companies must pay a facility registration fee based on their annual gross sales of cosmetics. The collected fees can only be used for cosmetic safety activities. If the FDA determines that a cosmetic has a reasonable probability of causing serious adverse health consequences, it may prohibit the cosmetic's distribution by suspending the cosmetic ingredient statement. If other cosmetics from the same facility may be affected, the FDA may prohibit distribution from the facility by suspending the facility's registration. The FDA must review the safety of at least five cosmetic ingredients each year, and it may establish conditions for safe use of an ingredient, including a limit on the amount of the ingredient or a requirement for a warning label. A cosmetic cannot be sold if it contains an ingredient that is not safe, not safe under the recommended conditions of use, or not safe in the amount present in the cosmetic. Cosmetics companies are required to report to the FDA any serious adverse health event associated with their cosmetics. The FDA must: develop and implement cosmetic manufacturing standards that are consistent with existing national and international standards, be allowed to inspect a company's cosmetic safety records, recall a cosmetic that is likely to cause serious adverse health consequences, and encourage cosmetic safety testing practices that minimize the use of animals.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 11 May 2017

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2918-2919)

   Source: IntroReferral

2. 11 May 2017

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 11 May 2017 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 11 May 2017

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 11 May 2017

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 11 May 2017

  Open at official source

Sponsors

• Sen. Feinstein, Dianne [D-CA] · D · Sponsor
• Susan Collins · R · Sponsor
• Amy Klobuchar · D · Cosponsor
• Michael Bennet · D · Cosponsor
• Sen. Udall, Tom [D-NM] · D · Cosponsor
• Sen. Hirono, Mazie K. [D-HI] · D · Cosponsor
• Christopher Coons · D · Cosponsor
• Sen. Leahy, Patrick J. [D-VT] · D · Cosponsor
• Shelley Capito · R · Cosponsor
• Rep. Cardin, Benjamin L. [D-MD-3] · D · Cosponsor
• Kirsten Gillibrand · D · Cosponsor
• Sen. Harris, Kamala D. [D-CA] · D · Cosponsor
• Richard Blumenthal · D · Cosponsor
• Maggie Hassan · D · Cosponsor
• Sheldon Whitehouse · D · Cosponsor
• Jeanne Shaheen · D · Cosponsor
• Angus King · I · Cosponsor
• · sshr00 · Standing

Related records

No cross-record relationships stored yet.